Xing Bian

508 total citations
12 papers, 350 citations indexed

About

Xing Bian is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Xing Bian has authored 12 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Oncology and 2 papers in Immunology. Recurrent topics in Xing Bian's work include Cancer therapeutics and mechanisms (5 papers), Lung Cancer Research Studies (5 papers) and PARP inhibition in cancer therapy (4 papers). Xing Bian is often cited by papers focused on Cancer therapeutics and mechanisms (5 papers), Lung Cancer Research Studies (5 papers) and PARP inhibition in cancer therapy (4 papers). Xing Bian collaborates with scholars based in China and United States. Xing Bian's co-authors include Wenchu Lin, Hong Li, Liying Ma, Pixu Liu, Hailing Cheng, Xiaolin Wang, Cheng Wu, Tianyi Yu, Shanshan Hu and Yongxiang Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cell Death and Disease and Oncotarget.

In The Last Decade

Xing Bian

12 papers receiving 347 citations

Peers

Xing Bian
Zixi Liang China
Wytske Boersma‐van Ek Netherlands
Yibin Lin China
Mohamed A. Elkady Egypt
Wan-Feng Gao China
Shumei Liang China
Da Zeng China
N. V. Yunusova Russia
Ziqin Liu China
Zixi Liang China
Xing Bian
Citations per year, relative to Xing Bian Xing Bian (= 1×) peers Zixi Liang

Countries citing papers authored by Xing Bian

Since Specialization
Citations

This map shows the geographic impact of Xing Bian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xing Bian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xing Bian more than expected).

Fields of papers citing papers by Xing Bian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xing Bian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xing Bian. The network helps show where Xing Bian may publish in the future.

Co-authorship network of co-authors of Xing Bian

This figure shows the co-authorship network connecting the top 25 collaborators of Xing Bian. A scholar is included among the top collaborators of Xing Bian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xing Bian. Xing Bian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Bian, Xing, et al.. (2024). Therapeutic targeting of PARP with immunotherapy in acute myeloid leukemia. Frontiers in Pharmacology. 15. 1421816–1421816. 1 indexed citations
2.
Bian, Xing, et al.. (2023). Targeting DNA Damage Repair and Immune Checkpoint Proteins for Optimizing the Treatment of Endometrial Cancer. Pharmaceutics. 15(9). 2241–2241. 2 indexed citations
3.
Ma, Liying, Xing Bian, & Wenchu Lin. (2021). Correction to: The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer. Journal of Experimental & Clinical Cancer Research. 40(1). 7–7. 18 indexed citations
4.
Li, Hong, et al.. (2021). FK228 sensitizes radioresistant small cell lung cancer cells to radiation. Clinical Epigenetics. 13(1). 41–41. 12 indexed citations
5.
Li, Ming, Yan Hua, Yayun Cui, et al.. (2021). Exosomal miR-92b-3p Promotes Chemoresistance of Small Cell Lung Cancer Through the PTEN/AKT Pathway. Frontiers in Cell and Developmental Biology. 9. 661602–661602. 34 indexed citations
6.
Wang, Xiaolin, Jingxin Li, Xing Bian, et al.. (2021). CircURI1 interacts with hnRNPM to inhibit metastasis by modulating alternative splicing in gastric cancer. Proceedings of the National Academy of Sciences. 118(33). 105 indexed citations
7.
Bian, Xing, Xiaolin Wang, Qiu‐Yan Zhang, et al.. (2020). The MYC Paralog-PARP1 Axis as a Potential Therapeutic Target in MYC Paralog-Activated Small Cell Lung Cancer. Frontiers in Oncology. 10. 565820–565820. 5 indexed citations
8.
Ma, Liying, Xing Bian, & Wenchu Lin. (2020). The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer. Journal of Experimental & Clinical Cancer Research. 39(1). 219–219. 28 indexed citations
9.
Wang, Yunlong, et al.. (2019). Study of the thermal performance of multilayer insulation used in cryogenic transfer lines. Cryogenics. 100. 114–122. 32 indexed citations
10.
Bian, Xing & Wenchu Lin. (2019). Targeting DNA Replication Stress and DNA Double-Strand Break Repair for Optimizing SCLC Treatment. Cancers. 11(9). 1289–1289. 10 indexed citations
11.
Gao, Jing, Ting Li, Xing Bian, et al.. (2018). Macrophages confer resistance to PI3K inhibitor GDC-0941 in breast cancer through the activation of NF-κB signaling. Cell Death and Disease. 9(8). 809–809. 31 indexed citations
12.
Wang, Dong, Min Wang, Nan Jiang, et al.. (2016). Effective use of PI3K inhibitor BKM120 and PARP inhibitor Olaparib to treat PIK3CA mutant ovarian cancer. Oncotarget. 7(11). 13153–13166. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zixi Liang Breakdown of academic impact, for papers by Wytske Boersma‐van Ek Breakdown of academic impact, for papers by Yibin Lin Breakdown of academic impact, for papers by Mohamed A. Elkady Breakdown of academic impact, for papers by Wan-Feng Gao Breakdown of academic impact, for papers by Shumei Liang Breakdown of academic impact, for papers by Da Zeng Breakdown of academic impact, for papers by N. V. Yunusova Breakdown of academic impact, for papers by Ziqin Liu
Rankless by CCL
2026